Ghana - Startup under 3 years old

Décrivez votre projet en quelques mots

We're building an AI-AUGMENTED Predictive algorithm designed to expedite the Drug discovery process by predicting the efficacy and side effect profile of a prospective drug. With this it can predict if will gain FDA Approval.

01.01 Décrivez votre startup en détail

Hermes-Soft Technologies is building an innovative AI-powered predictive algorithm that can accurately forecast the likelihood of drug candidates passing the critical human clinical trial phase of the approval process. This technology addresses a major pain point in the pharmaceutical industry - the high failure rates and immense costs associated with drug development. Market Opportunity: The global pharmaceutical R&D market is massive, estimated at over $200 billion annually. However, the drug discovery process is notoriously inefficient, with only about 12% of drug candidates making it through clinical trials. Hermes-Soft's technology has the potential to drastically improve R&D productivity and success rates, representing a multi-billion dollar market opportunity.

01.02 Quel est le problème principal que vous essayez de résoudre ?

On the average, it takes 10 to 16 years to get a drug approved by the FDA. The aim is to help bring that duration down. If the duration comes, it helps bring new therapies to patients who need them faster, contributing to the overall well-being of mankind. In addition, Traditional drug discovery processes are highly inefficient. It can 10 years to research a prospective drug, only for it to pass the Animal testing phase yet Fail the Human Trials stage. This can costs billions of dollars to the company. Failure rate of prospective compounds is at 88%, we want to decrease that.

01.03 Dites-nous quels sont les principaux avantages et/ou bénéfices de l'utilisation du produit/service fourni par votre startup (au moins 3).

1. Dramatically Improved R&D Productivity: Hermes-Soft's 90%+ accurate forecasts enable customers to focus resources on the most promising drug candidates, increasing the probability of successful development by 30-50%. 2. Substantial Cost Savings: By reducing costly late-stage failures, Hermes-Soft can save customers billions of dollars in R&D expenses, which can be reinvested into accelerating new treatments. 3. Accelerated Time-to-Market: Hermes-Soft's technology allows pharmaceutical companies to navigate the drug development pipeline faster, shortening the 10+ year average timeline for bringing a new drug to market. In summary, Hermes-Soft's cutting-edge predictive algorithms empower its customers to develop new drugs more efficiently, cost-effectively, and quickly - driving immense value across the entire pharmaceutical value chain.

01.04 Veuillez décrire précisément à qui s'adresse le produit/service de votre startup. Quels sont les bénéficiaires visés ?

Hermes-Soft's predictive algorithm is designed to benefit a diverse range of organizations involved in drug discovery and development: - Pharmaceutical/Biotech Firms: Large pharmaceutical and biotech companies with substantial R&D budgets and active drug pipelines. - Research Institutions: Academic and private research centers conducting preclinical and clinical studies. - Academic Institutions: Universities and colleges exploring new drug candidates and therapies. - Government Organizations: Public health agencies and regulatory bodies overseeing the drug approval process. - NGOs: Non-profit organizations focused on developing treatments for underserved patient populations. By leveraging Hermes-Soft's over 90% accurate forecasts, these varied beneficiaries can make more informed decisions, increase R&D productivity, and reduce costly late-stage failures. This translates to substantial cost savings that can be reinvested into accelerating innovative new treatments.

01.05 Quand votre entreprise a-t-elle été créée ?

13/10/2023

01.06 Vendez-vous déjà votre produit/service ?

Non

01.07 Combien y a-t-il de propriétaires de votre entreprise en plus de vous ?

0

01.08 Parmi les autres propriétaires, combien sont des femmes ?

0

01.09 Veuillez décrire le profil des autres propriétaires de votre startup (compétences, expérience, etc.).

Hermes-Soft Technologies' experienced and multitalented founding team gives the company a distinct advantage in tackling the challenges of drug discovery and development: 1. Domain Expertise: The founder's background as a pharmacist with nearly a decade of industry experience provides deep, first-hand insights into the pain points and limitations of the current R&D process. 2. Entrepreneurial Acumen: As a serial entrepreneur, the founder has a proven track record of launching successful ventures and navigating the complexities of building a technology business. 3. Creative Problem-Solving: The founder's background as a screenwriter brings a unique creative perspective to formulating innovative solutions - a valuable asset for reimagining a stagnant industry. 4. Cross-Disciplinary Collaboration: The diverse expertise spanning pharmaceuticals, entrepreneurship, and creative thinking allows the founding team to approach the problem from multiple angles.

01.10 Si vous avez un site web, une page sur les médias sociaux (Facebook, Instagram, Linkedin...) ou une application, veuillez fournir le(s) lien(s) ici :

01.11 Quel est le secteur d'activité qui décrit le mieux votre entreprise ?

Soins de santé (équipements et services de santé)

02.01.01 Ma startup contribue à l'objectif 'Pas de pauvreté'

3

02.01.02 Justification de la contribution de ma startup

By providing employment to Programmers, Retired Scientific consultants, we contribute to decreasing unemployment.

02.02.01 Ma startup contribue à l'objectif 'Faim Zéro'

3

02.02.02 Justification de la contribution de ma startup

By providing employment, we enable families to be able to provide a daily three square meal for themselves.

02.03.01 Ma startup contribue à l'objectif 'Bonne Santé et Bien Être'

7 - tout à fait d'accord

02.03.02 Justification de la contribution de ma startup

Hermes-Soft's predictive algorithm directly supports the UN Sustainable Development Goal of Ensuring Healthy Lives and Promoting Well-Being for All. By accelerating the development and delivery of new treatments, the algorithm expands access to life-saving medicines. It shortens the 10+ year drug discovery timeline, enabling patients to receive innovative therapies years faster. This increased speed also allows for a broader range of affordable treatment options, especially for underserved populations. Moreover, the algorithm's high accuracy in forecasting clinical trial outcomes ensures limited patient and resource pools are directed towards the most promising drug candidates. This improves overall R&D productivity and success rates, further driving down costs and time-to-market. Ultimately, Hermes-Soft's transformative technology is poised to save and improve countless lives globally.

02.04.01 Ma startup contribue à l'objectif 'Éducation de Qualité'

3

02.04.02 Justification de la contribution de ma startup

Educational Outreach and Partnerships: - We are working to establish partnerships with leading universities and research institutions to offer educational programs, workshops, and internships focused on AI, machine learning, and drug discovery.

02.05.01 Ma startup contribue à l'objectif 'Égalité entre les Sexes'

5

02.05.02 Justification de la contribution de ma startup

Hermes-Soft Technologies' solutions have the potential to meaningfully contribute to the UN Sustainable Development Goal of Gender Equality by: 1. Promoting Women in STEM: The company's focus on advanced AI and machine learning technology provides opportunities for women to take on leadership roles in the fields of computer science, data analytics, and drug discovery research - historically male-dominated areas. 2. Supporting Women Entrepreneurs: By empowering pharma and biotech startups, many of which are founded by women, Hermes-Soft's technology helps facilitate female entrepreneurship and the growth of women-led businesses in the life sciences sector. 3. Improving Healthcare Access for Women: The algorithm's ability to accelerate the development and lower the costs of new treatments has a direct positive impact on women's healthcare, especially in regions where access to quality medical services remains limited. 4. Addressing Gender-Specific Diseases.

02.06.01 Ma startup contribue à l'objectif 'Eau Propre et Assainissement'

2

02.06.02 Justification de la contribution de ma startup

02.07.01 Ma startup contribue à l'objectif 'Énergie Propre et Abordable'

6

02.07.02 Justification de la contribution de ma startup

We are committed to operating our business in a sustainable and environmentally responsible manner. By optimizing our energy consumption, reducing waste, and implementing green practices, we aim to minimize our environmental footprint and contribute to the long-term sustainability of economic development.

02.08.01 Ma startup contribue à l'objectif 'Travail Décent et Croissance Économique'

7 - tout à fait d'accord

02.08.02 Justification de la contribution de ma startup

Hermes-Soft Technologies is committed to contributing to the United Nations Sustainable Development Goal (SDG) of promoting sustained, inclusive, and sustainable economic growth, as well as full and productive employment and decent work for all. Firstly, our AI-powered drug discovery platform has the potential to significantly enhance the efficiency and productivity of the pharmaceutical industry, which is a major driver of economic growth. By accelerating the drug development process and reducing the overall costs, our technology can help pharmaceutical companies bring life-saving treatments to market faster, ultimately improving patient outcomes and contributing to a healthier global population. Secondly, we prioritize the creation of high-quality, well-paying jobs within our own organization. We are dedicated to building a diverse and inclusive workforce, with a focus on providing competitive compensation, comprehensive benefits, and opportunities for professional development and

02.09.01 Ma startup contribue à l'objectif 'Industrie, Innovation et Infrastructure'

7 - tout à fait d'accord

02.09.02 Justification de la contribution de ma startup

Hermes-Soft Technologies is committed to contributing to the United Nations Sustainable Development Goal (SDG) of building resilient infrastructure, promoting inclusive and sustainable industrialization, and fostering innovation. As a technology-driven company at the forefront of AI-powered drug discovery, we are actively driving innovation in the pharmaceutical industry. Our cutting-edge computational models and machine learning algorithms are revolutionizing the drug development process, enabling faster, more efficient, and more cost-effective discovery and optimization of new drug candidates. To support this innovation, we have invested heavily in building a robust and scalable infrastructure. Our cloud-native architecture, leveraging the latest advancements in areas such as big data, high-performance computing, and containerization, allows us to rapidly process and analyze massive datasets, accelerating the pace of scientific discovery.

02.10.01 Ma startup contribue à l'objectif 'Réduction des Inégalités'

6

02.10.02 Justification de la contribution de ma startup

Hermes-Soft Technologies is committed to contributing to the United Nations Sustainable Development Goal (SDG) of reducing inequalities within and among communities. One of our key initiatives in this area is our focus on building a diverse and inclusive workforce. We actively recruit talent from various backgrounds, prioritizing equal opportunities for individuals regardless of their gender, race, ethnicity, age, or socioeconomic status. Our hiring practices and corporate policies are designed to foster an environment of respect, inclusivity, and equal treatment. Furthermore, we are dedicated to providing our employees with fair and competitive compensation, comprehensive benefits, and ample opportunities for professional development and advancement. By investing in the growth and well-being of our workforce, we aim to create a more equitable work environment and serve as a role model for other institutions.

02.11.01 Ma startup contribue à l'objectif 'Villes et Communautés Durables'

4

02.11.02 Justification de la contribution de ma startup

Hermes-Soft Technologies is committed to contributing to the United Nations Sustainable Development Goal (SDG) of making cities and human settlements inclusive, safe, resilient, and sustainable. As a technology company, we recognize the critical role that innovation and infrastructure play in shaping the future of our urban environments. To this end, we are actively exploring ways to leverage our expertise in areas such as AI, data analytics, and cloud computing to support the development of smart and sustainable cities.

02.12.01 Ma startup contribue à l'objectif 'Consommation et Production Responsables'

4

02.12.02 Justification de la contribution de ma startup

Hermes-Soft Technologies is committed to contributing to the United Nations Sustainable Development Goal (SDG) of ensuring responsible consumption and production patterns. As a technology-driven company, we recognize the environmental impact of our operations and are taking proactive steps to minimize our footprint and promote sustainable practices throughout our value chain.

02.13.01 Ma startup contribue à l'objectif 'Lutte contre les Changements Climatiques'

4

02.13.02 Justification de la contribution de ma startup

Our Startup is Health centered and therefore does contribute significantly to this goal.

02.14.01 Ma startup contribue à l'objectif 'Vie Sous-Marine'

4

02.14.02 Justification de la contribution de ma startup

Our Startup is Health centered and therefore does contribute significantly to this goal.

02.15.01 Ma startup contribue à l'objectif 'Vie Terrestre'

2

02.15.02 Justification de la contribution de ma startup

Our Startup is Health centered and therefore does contribute significantly to this goal.

02.16.01 Ma startup contribue à l'objectif 'Paix, Justice et Institutions Efficaces'

4

02.16.02 Justification de la contribution de ma startup

Hermes-Soft Technologies is committed to contributing to the United Nations Sustainable Development Goal (SDG) of promoting peaceful and inclusive societies, providing access to justice, and building effective, accountable, and inclusive institutions. As a responsible corporate citizen, we place a strong emphasis on good governance, transparency, and ethical business practices. Our corporate policies and code of conduct strictly prohibit any form of corruption, bribery, or unethical behavior, and we have implemented robust compliance mechanisms to ensure adherence across our organization. We also recognize the importance of upholding the rule of law and protecting human rights. Our partnerships and collaborations with research institutions, governments, and civil society organizations are guided by principles of inclusivity, non-discrimination, and respect for the dignity of all individuals.

02.17.01 Ma startup contribue à l'objectif 'Parteneriats pour la Réalisation des Objectifs'

5

02.17.02 Justification de la contribution de ma startup

Hermes-Soft Technologies is committed to contributing to the United Nations Sustainable Development Goal (SDG) of strengthening global partnerships for sustainable development. As a technology-driven company, we recognize the importance of collaboration and the power of collective action in addressing the complex challenges facing our world. To this end, we have proactively forged partnerships and alliances with a diverse range of stakeholders, including governments, non-profit organizations, academic institutions, and other private-sector entities. One of our key initiatives in this area is the establishment of our Global Partnership Program. Through this platform, we work closely with our partners to identify and co-create innovative solutions that can drive progress towards the SDGs. We leverage our technological expertise, data-driven insights, and industry-leading capabilities to support the development and deployment of sustainable practices and technologies. For example, we h

06.01 Un grand nombre de clients utilisent déjà un produit/service très similaire au nôtre.

3

06.02 Notre produit/service représente un type de produit/service entièrement nouveau

5

06.03 Notre produit/service pourrait être décrit comme une nouvelle technologie

5

06.04 Notre produit/service est une amélioration d'un produit ou d'un service existant

7 - Tout à fait d'accord

06.05 Notre produit/service pourrait être décrit comme une extension d'une gamme de produits ou de services

7 - Tout à fait d'accord

06.06 Notre produit/service répond à une demande ou à un besoin qui n'a pas été satisfait par d'autres produits/services.

6

06.07 Notre produit/service est une nouvelle version d'un ancien produit/service

7 - Tout à fait d'accord

06.08 Justification

Hermes-Soft Technologies' idea of an AI-augmented predictive algorithm for drug discovery is truly innovative and unique, as it addresses a critical gap in the current landscape of AI-driven drug discovery models. Most existing AI drug discovery approaches focus solely on using molecular databases to generate novel drug candidates, often overlooking the crucial challenge of predicting the likelihood of a drug successfully passing through human clinical trials and gaining FDA approval. Hermes-Soft Technologies recognizes that this gap in the drug discovery process is a significant bottleneck, as many promising drug candidates fail during the later stages of development due to unforeseen issues related to efficacy, safety, or regulatory approval. By developing an AI-augmented predictive algorithm, Hermes-Soft Technologies aims to enhance the decision-making process by incorporating a comprehensive set of variables beyond just molecular data.

06.09 Analyse compétitive

our main potential competitors include: 1. Traditional Pharmaceutical Companies with In-house AI/ML Capabilities: Many large pharmaceutical companies have invested heavily in developing their own AI and machine learning capabilities to support drug discovery and development. 2. Specialized AI Drug Discovery Startups: There are several startups that have emerged in recent years, offering AI-powered solutions for drug discovery.

11.05 Menez-vous des actions au sein de votre communauté pour promouvoir le rôle des femmes entrepreneurs ?